AMI Asset Management
ARQT icon

AMI Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History

AMI Asset Management’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.1M Buy
41,505
+4,384
+12% +$115K 0.06% 48
2026
Q2 		$973K Sell
37,121
-13,742
-27% -$320K 0.06% 61
2026
Q1 		$1.2M Buy
50,863
+1,601
+3% +$40.9K 0.08% 45
2025
Q4 		$1.43M Sell
49,262
-46,829
-49% -$1.2M 0.08% 46
2025
Q3 		$1.81M Sell
96,091
-17,791
-16% -$281K 0.1% 39
2025
Q2 		$1.6M Sell
113,882
-94,839
-45% -$1.33M 0.09% 39
2025
Q1 		$3.26M Sell
208,721
-7,237
-3% -$102K 0.19% 39
2024
Q4 		$3.01M Sell
215,958
-7,723
-3% -$84.6K 0.16% 39
2024
Q3 		$2.08M Buy
223,681
+59,487
+36% +$587K 0.11% 42
2024
Q2 		$1.53M Sell
164,194
-181,045
-52% -$1.64M 0.08% 52
2024
Q1 		$3.42M Buy
+345,239
New +$2.58M 0.17% 57

Other funds holding ARQT

Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Jay A. Fishman Ltd
Jay A. Fishman Ltd Troy, Michigan $1.24B AUM 21.21% 1-Year Est. Return
Pavaki Capital Management
Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
OpenArc Corporate Advisory
OpenArc Corporate Advisory Atlanta, Georgia $8.86B AUM 19.31% 1-Year Est. Return
Yousif Capital Management
Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

AMI Asset Management's ARQT Position: Q3 2026 in Review

AMI Asset Management increased its Arcutis Biotherapeutics (ARQT) stake by 12% in Q3 2026, buying an estimated $115K and bringing the position to 41,505 shares worth $1.1M. The position accounts for 0.06% of the portfolio, ranked #48.

AMI Asset Management first reported a position in ARQT in Q1 2024 and has held it in 11 quarters since. The position peaked at $3.42M in Q1 2024. 51 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.

  • AMI Asset Management held 41,505 shares of Arcutis Biotherapeutics worth $1.1M as of Q3 2026.
  • AMI Asset Management bought 4,384 Arcutis Biotherapeutics shares in Q3 2026, an estimated $115K.
  • Arcutis Biotherapeutics made up 0.06% of AMI Asset Management's portfolio in Q3 2026, its #48 holding.
  • AMI Asset Management first reported a position in Arcutis Biotherapeutics in Q1 2024 and has held it in 11 quarters since.
  • AMI Asset Management's Arcutis Biotherapeutics position peaked at $3.42M in Q1 2024.
  • 51 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.

Based on AMI Asset Management's 13F filing for Q3 2026, filed 20 Oct 2026.